Pharmafile Logo

Virtually, the same: Is it time to rethink congress strategy?

- PMLiVE

In this month’s PME, Jonathan Andrew, Technology Director at Lucid Group discusses the digital transformation that swept through the medcomms industry due to the COVID-19 pandemic. In particular, we saw the entire pharmaceutical congress scene turned on its head as the world went into lockdown, bringing face-to-face gatherings to an abrupt halt. The congress organisers, pharma firms and their logistics/creative med-comms agencies rallied at speed to adjust to the new normal of running events virtually, and still managed to still put on an excellent show.

Twelve months on, we now have a year’s worth of learnings and engagement metrics to reflect on; but what, if anything, has changed? What might ‘good’ look like, considering the insight?

In this article, Jonathan reflects on the key learnings which will help to shape the delivery of a new hybrid approach to post-pandemic medical meetings and congresses.

“By attempting to create a like-for-like congress environment – complete with 3D-virtual exhibition halls and 3D-virtual booths, we have inadvertently broken what makes an online experience great, and subsequently made content much harder for delegates to locate and interact with.”

You can access and download the full article here.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016

The PMEA programme rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes. The awards have been specifically designed to recognise and commend excellence, best...

Lucid bolsters its senior leadership team

Lucid Group has had a successful summer attracting top talent to its senior leadership team with the appointment of Shula Sarner (Executive Scientific Director) and Tanya Goodyear (Division Director, Immunology).

IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

Lucid Group becomes a sponsor of MedComms Networking

To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...

Lucid launch new recruitment campaign to attract top talent in medical writing

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

Making a difference together

It was highlighted at the 2016 World Economic Forum that ‘good business’ now means more than financial success, with multiple stakeholders asking how business will benefit society. At Lucid, our...

Lucid Group take time out for work and play at their annual Summer Meeting

Lucid Group may be an award-winning medical education agency, packed with industry-leading talent, but it still understands how important it is to provide the best customer experience possible. 2015 was an...

Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications

From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference...